APA (7th ed.) Citation

L, D., B, B., AW, A., CG, B., J, D. R., SR, D., . . . M, L. (2026). The role of aryl hydrocarbon receptor agonists in the management of inflammatory skin diseases: An expert consensus panel. Dermatology online journal, 32(3), . https://doi.org/10.25251/ha2gbq97

Chicago Style (17th ed.) Citation

L, DeBusk, et al. "The Role of Aryl Hydrocarbon Receptor Agonists in the Management of Inflammatory Skin Diseases: An Expert Consensus Panel." Dermatology Online Journal 32, no. 3 (2026). https://doi.org/10.25251/ha2gbq97.

MLA (9th ed.) Citation

L, DeBusk, et al. "The Role of Aryl Hydrocarbon Receptor Agonists in the Management of Inflammatory Skin Diseases: An Expert Consensus Panel." Dermatology Online Journal, vol. 32, no. 3, 2026, https://doi.org/10.25251/ha2gbq97.